Metraipolis › archive › dc_28917a7d36cd

Transcriptomic and Clinical Profiling Reveals LGALS3 as a Prognostic Oncogene in Pancreatic Cancer — Europe PMC PMID:41153387

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41153387
DOI
10.3390/genes16101170
License (as archived)
solo-consultazione
Archived
2026-11-09T14:03:35.642Z
SHA-256 of the archived text
3152f42c3763668109878872691639690efb8c5109d3be92744efdeddd088824
Stable URL of this page
https://metraipolis.com/documento/dc_28917a7d36cd

How to cite

Transcriptomic and Clinical Profiling Reveals LGALS3 as a Prognostic Oncogene in Pancreatic Cancer — Europe PMC PMID:41153387 — Europe PMC (en), https://europepmc.org/article/MED/41153387 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_28917a7d36cd (Metraipolis archive dc_28917a7d36cd, sha256 3152f42c3763668109878872691639690efb8c5109d3be92744efdeddd088824)
BibTeX
@misc{dc28917a7d36cd,
  title = {Transcriptomic and Clinical Profiling Reveals LGALS3 as a Prognostic Oncogene in Pancreatic Cancer — Europe PMC PMID:41153387},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41153387},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_28917a7d36cd; sha256 3152f42c3763668109878872691639690efb8c5109d3be92744efdeddd088824},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41153387. Agents can read the archived copy with the MCP tool read_document.